// App-Quantinova.ai

P2-06-09 : Prediction of relapse in patients with locally advanced breast cancer after neoadjuvant treatment

Researchers

Presenter

  • O Aseyev

Principal Investigators

  • L Simmonds

  • M Gertler

  • S Dent

  • S Verma

Medical Centers

  • The Ottawa Hosp Cancer Centre / Univ of Ottawa, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab

  • Paclitaxel

  • Docetaxel

  • Tamoxifen

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim